Journal profile · Medicine-Cardiology and Cardiovascular Medicine
Zhongguo dongmai yinghua zazhi
ISSN 1007-3949 · Editorial Office of Chinese Journal of Arteriosclerosis · China
FollowGet an email when its zone, impact factor or warning status changes
Zhongguo dongmai yinghua zazhi: fully open access; APC charged, amount not published; review about 32 weeks (community reports); 0 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Zhongguo dongmai yinghua zazhi is published by Editorial Office of Chinese Journal of Arteriosclerosis. By OpenAlex counts of its recent articles, its largest topics are Atherosclerosis and Cardiovascular Diseases, Cholesterol and Lipid Metabolism and Lipoproteins and Cardiovascular Health, together about 35% of its articles. Its main subfields are Surgery and Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
The publishing scope of the journal includes the prevention and treatment of arteriosclerotic diseases (such as hyperlipidemia, coronary artery disease, ischemic cerebrovascular disease, hypertension, arteriosclerosis and other ischemic diseases) in traditional Chinese medicine, preventive medicine, basic medicine, clinical medicine, pharmacology and special medicine. The columns include original research article (including epidemiological research, experimental research, clinical research and methodological research), review, diagnosis and treatment experience, case report, lectures, etc. The aim of the journal is to report cutting-edge theories, viewpoints, therapies and new drugs for the prevention and treatment of arteriosclerotic diseases, introduce new experience and knowledge of prevention and control, facilitate academic research and promote academic exchanges at home and abroad, and promote the improvement of human health.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Cardiology and Cardiovascular Medicine
Main research topics OpenAlex counts of recent articles; shares are approximate
- Atherosclerosis and Cardiovascular DiseasesImmunology and Microbiology16.1%
- Cholesterol and Lipid MetabolismMedicine10.1%
- Lipoproteins and Cardiovascular HealthMedicine8.9%
- Nitric Oxide and Endothelin EffectsMedicine8.5%
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine4.2%
- Cardiovascular Health and Disease PreventionMedicine3.9%
- Renin-Angiotensin System StudiesMedicine3.9%
- Acute Myocardial Infarction ResearchMedicine3.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Cardiology and Cardiovascular Medicine | Q4 | 329/409 | 19th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
CNKI, Chemical Abstract (CA), Russian Abstract Journal (AJ), Wanfang Data, Chinese Academic Journals (CNKI)Publisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
- CiteScore 2026-06
- 0.8LetPub ·
- SJR 2026-06
- 0.12LetPub ·
- SNIP 2026-06
- 0.14LetPub ·
- h-index
- 4OpenAlex ·
- i10-index
- 0OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 1,995 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2025 | 0 | 0 | 2 |
| 2024 | 0 | 0 | 7 |
| 2023 | 0 | 0 | 2 |
| 2022 | 0 | 0 | 7 |
| 2021 | 0 | 0 | 8 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 32 weeksLetPub ·
- Submission to publication (journal-reported)
- about 32 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | CNY 3,500 | No | CC BY-NC-ND | |
| LetPub | CNY 3,500 | No | — | |
| Publisher website | CNY 300 / CNY 100 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Keywords
- ≥ 3
- Manuscript length
- ≤ 10,000 words
- Reference style
- Vancouver
- Templates
- Word
Article types accepted22
- case reportThe columns include original research article (including epidemiological research, experimental research, clinical research and methodological research), review…Length not stated
- case reportsOther columns welcome authors to submit articles of atherosclerosis in the field of basic medicine, clinical medicine, biology, traditional Chinese medicine and…Length not stated
- clinical researchOther columns welcome authors to submit articles of atherosclerosis in the field of basic medicine, clinical medicine, biology, traditional Chinese medicine and…Length not stated
- diagnosis and treatmentOther columns welcome authors to submit articles of atherosclerosis in the field of basic medicine, clinical medicine, biology, traditional Chinese medicine and…Length not stated
- diagnosis and treatment experienceThe columns include original research article (including epidemiological research, experimental research, clinical research and methodological research), review…Length not stated
- discussionOther columns welcome authors to submit articles of atherosclerosis in the field of basic medicine, clinical medicine, biology, traditional Chinese medicine and…Length not stated
- epidemiologyOther columns welcome authors to submit articles of atherosclerosis in the field of basic medicine, clinical medicine, biology, traditional Chinese medicine and…Length not stated
- experimental researchOther columns welcome authors to submit articles of atherosclerosis in the field of basic medicine, clinical medicine, biology, traditional Chinese medicine and…Length not stated
- lecturesThe columns include original research article (including epidemiological research, experimental research, clinical research and methodological research), review…Length not stated
- literature reviewOther columns welcome authors to submit articles of atherosclerosis in the field of basic medicine, clinical medicine, biology, traditional Chinese medicine and…Length not stated
- methodological researchOther columns welcome authors to submit articles of atherosclerosis in the field of basic medicine, clinical medicine, biology, traditional Chinese medicine and…Length not stated
- newsOther columns welcome authors to submit articles of atherosclerosis in the field of basic medicine, clinical medicine, biology, traditional Chinese medicine and…Length not stated
- newslettersOther columns welcome authors to submit articles of atherosclerosis in the field of basic medicine, clinical medicine, biology, traditional Chinese medicine and…Length not stated
- original research articleThe columns include original research article (including epidemiological research, experimental research, clinical research and methodological research), review…Length not stated
- perspectiveThe column of Perspective is contributed by invited experts.Length not stated
- reviewThe columns include original research article (including epidemiological research, experimental research, clinical research and methodological research), review…Length not stated
- short articleOther columns welcome authors to submit articles of atherosclerosis in the field of basic medicine, clinical medicine, biology, traditional Chinese medicine and…Length not stated
- 文献综述文献综述Length not stated
- 病例报道病例报道Length not stated
- 知识讲座知识讲座Length not stated
- 研究论文研究论文（含流行病学研究、实验研究、临床研究和方法学研究）Length not stated
- 诊治经验诊治经验Length not stated
Policy excerpts from the journal's websiteAuthorship, Open access
- Authorship
No co-first author or co-corresponding author Model summary
The journal does not accept co-first author or co-corresponding author.
Source ↗Publisher website ·- Open access
Open access; all published articles can be read and downloaded free of charge from the website. Model summary
Chinese Journal of Arteriosclerosis is an open access journal. All article published could be read and downloaded free of charge from this website.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Before you submit
Four checks before submitting to Zhongguo dongmai yinghua zazhi
- 1ScopeRecent output centres on Atherosclerosis and Cardiovascular Diseases, Cholesterol and Lipid Metabolism.Check scope
- 2Article type and formatKeywords: ≥ 3; Manuscript length: ≤ 10,000 words; Reference style: Vancouver.Author guidelines ↗
- 3FeesCNY 3,500 (DOAJ)Fee details
- 4Expected review timeabout 32 weeks · Community averageReview data
The checks are built from this page's data.
Profile
Publication details and official links
- Publisher
- Editorial Office of Chinese Journal of Arteriosclerosis
- Country or region
- China
- Language
- Chinese
- ISSN
- 1007-3949
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Zhongguo dongmai yinghua zazhi
How long does peer review take at Zhongguo dongmai yinghua zazhi?
Authors report an average review time of about 32 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Zhongguo dongmai yinghua zazhi?
According to the journal's author guidelines: Keywords: ≥ 3; Manuscript length: ≤ 10,000 words; Reference style: Vancouver; Templates: Word. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Which databases index Zhongguo dongmai yinghua zazhi?
According to LetPub and DOAJ records, Zhongguo dongmai yinghua zazhi is indexed in Scopus and DOAJ.
Is Zhongguo dongmai yinghua zazhi open access, and what is the APC?
Zhongguo dongmai yinghua zazhi is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .